Risk of genital and urinary tract infections associated with SGLT‐2 inhibitors as an add‐on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea

Sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors are antidiabetic drugs with associated safety concerns regarding the risk of genital and urinary tract infections. This study assessed the risk of genital and urinary tract infections associated with prescription of SGLT‐2 inhibitors as an add‐on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hyeri, Choi, Eunmi, Park, Eunjun, Na, Eonji, Chung, Soo Youn, Kim, Bonggi, Han, Soon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Invited Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929338/
https://www.ncbi.nlm.nih.gov/pubmed/35005849
http://dx.doi.org/10.1002/prp2.910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929338/
https://www.ncbi.nlm.nih.gov/pubmed/35005849
http://dx.doi.org/10.1002/prp2.910

Ejemplares similares